Roche Gets FDA EUA for H1N1 Test Kit | GenomeWeb

NEW YORK (GenomeWeb News) – Roche has become the latest firm to receive an Emergency Use Authorization from the US Food and Drug Administration for a 2009 H1N1 influenza test kit.

The firm said today that the FDA has granted the EUA for its RealTime ready Influenza A/H1N1 Detection Set. The kit rapidly detects RNA from the 2009 H1N1 influenza A virus and is used in conjunction with Roche's RealTime ready RNA Virus Master kit.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: proteomic consequences of genomic changes in ovarian cancer, Human SRMAtlas, and more.

At Nature, John Wilbanks and Eric Topol call for openness in health data.

Law.com predicts that genomic and genetic testing will become common in toxic tort cases.

A Pew Research Center report finds that most Americans are wary of using technologies like gene editing to enhance human abilities.